News

Mark Cuban, a self-made billionaire, believes in shrinking the government but emphasizes the need for a well-defined plan and transparency to avoid unintended consequences. He criticizes the current approach as "ready, fire, aim," advocating for a more measured strategy that minimizes disruption and communicates the rationale behind the cuts.

Fundstrat's Tom Lee believes markets are poised for a rebound despite widespread investor anxiety ahead of President Donald Trump's anticipated tariff announcement on Wednesday. Lee sees Bitcoin as a potential leader in the rebound and believes post-Wednesday announcements will provide more clarity and alleviate some selling pressure.

Cryptocurrency markets are currently experiencing a period of sideways trading, with investors anticipating the potential impact of upcoming tariff announcements on Wednesday. Despite some bearish sentiment in the medium term, experts like BlackRock CEO Larry Fink and Tom Lee remain optimistic about Bitcoin's future, citing its potential to rival the US dollar as a global reserve currency and its strong technical outlook.

President Donald Trump has appointed journalist Sara Carter as the next director of the Office of National Drug Control Policy, praising her commitment to fighting the opioid and fentanyl crisis. Carter, a former Fox News contributor, supports medical marijuana and has no issue with legalizing cannabis for recreational use, as long as it is properly monitored.

The article explores a shift in pain management away from opioids toward new, non-addictive treatments developed by companies like Vertex Pharmaceuticals and Tonix Pharmaceuticals. It highlights Vertex’s recent FDA approval for an acute pain treatment and discusses the promising potential of Tonix’s candidate drug for fibromyalgia, along with the broader outlook for both acute and chronic pain markets.